Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled heparin in cystic fibrosis
ISRCTN78613729Phase 2Completed
- Sponsor
- Vectura
- Start
- Nov 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised trial of heparin in cystic fibrosis (CF) (4 arms), sponsored by Vectura. Primary endpoint: Safety and tolerability. Started Nov 2008; status: completed.
02
Drugs
heparin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on ISRCTN78613729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN78613729.